ID: ALA5276939

Max Phase: Preclinical

Molecular Formula: C10H5F3O2S

Molecular Weight: 246.21

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc2cc(C(F)(F)F)ccc2s1

Standard InChI:  InChI=1S/C10H5F3O2S/c11-10(12,13)6-1-2-7-5(3-6)4-8(16-7)9(14)15/h1-4H,(H,14,15)

Standard InChI Key:  ROIKYRUNAMGSHG-UHFFFAOYSA-N

Associated Targets(Human)

C-type lectin domain family 4 member M 115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 246.21Molecular Weight (Monoisotopic): 245.9962AlogP: 3.62#Rotatable Bonds: 1
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.32CX Basic pKa: CX LogP: 3.52CX LogD: 0.10
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.83Np Likeness Score: -1.62

References

1. Sethi A, Sanam S, Alvala M..  (2021)  Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.,  222  [PMID:34146913] [10.1016/j.ejmech.2021.113561]

Source